Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2026-05-28 @ 5:31 AM
Study NCT ID:
NCT01357135
Status:
COMPLETED
Last Update Posted:
2017-06-05
First Post:
2011-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Type 2 Diabetes Mellitus | View |
Keywords: